Tag Archives: Tysabri
-
-
FDA Initiates Program to Target Misleading Drug Ads
-
FDA Warns Drug Maker For Minimizing Risk of Brain Infection from Tysabri
-
Tysabri Brain Infection Risk Increases with Number of Infusions: FDA
-
Additional PML Brain Infection Cases Linked to Tysabri and Rituxan
-
Tysabri Reactivates JC Virus Linked to Rare Brain Disease: Study
-
PML Brain Infection from Tysabri Reported in 10th Patient
-
Tysabri Side Effects Linked to 9th PML Infection Case
-
Another Tysabri Brain Infection Reported: 8th PML Infection Since Re-Launch
-
Rituxan Fatal Infections Lead FDA to Review Risk of Side Effects